ReviewCNS drugs2014

Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued.

Annalisa PinnaPubMed ↗Publisher ↗

No numbers read from the abstract.